- Home
- URGN vs THR Comparison
URGN vs THR Comparison
Compare URGN & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URGN
- THR
- Stock Information
- Founded
- URGN 2004
- THR 1954
- Country
- URGN United States
- THR United States
- Employees
- URGN N/A
- THR N/A
- Industry
- URGN Biotechnology: Pharmaceutical Preparations
- THR Industrial Machinery/Components
- Sector
- URGN Health Care
- THR Energy
- Exchange
- URGN Nasdaq
- THR Nasdaq
- Market Cap
- URGN 904.0M
- THR 829.9M
- IPO Year
- URGN 2017
- THR 2011
- Fundamental
- Price
- URGN $18.94
- THR $26.07
- Analyst Decision
- URGN Strong Buy
- THR
- Analyst Count
- URGN 8
- THR 0
- Target Price
- URGN $28.50
- THR N/A
- AVG Volume (30 Days)
- URGN 1.1M
- THR 202.2K
- Earning Date
- URGN 11-05-2025
- THR 11-06-2025
- Dividend Yield
- URGN N/A
- THR N/A
- EPS Growth
- URGN N/A
- THR 9.96
- EPS
- URGN N/A
- THR 1.58
- Revenue
- URGN $94,238,000.00
- THR $491,979,000.00
- Revenue This Year
- URGN $35.60
- THR $3.24
- Revenue Next Year
- URGN $129.54
- THR $5.61
- P/E Ratio
- URGN N/A
- THR $15.78
- Revenue Growth
- URGN 10.85
- THR N/A
- 52 Week Low
- URGN $3.42
- THR $23.05
- 52 Week High
- URGN $21.71
- THR $33.25
- Technical
- Relative Strength Index (RSI)
- URGN 49.18
- THR 49.90
- Support Level
- URGN $18.45
- THR $24.49
- Resistance Level
- URGN $21.71
- THR $26.56
- Average True Range (ATR)
- URGN 1.18
- THR 0.81
- MACD
- URGN -0.17
- THR 0.04
- Stochastic Oscillator
- URGN 20.90
- THR 59.70
About URGN UroGen Pharma Ltd.
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.